These mutations, occurring in the KIT or platelet-derived growth factor receptor alpha (PDGFRA) genes, drive aberrant signaling cascades, resulting in sustained growth, proliferation, and inhibition of apoptosis, ultimately leading to the development of GIST [4,5]. Here, PDGFRA is linked to gastrointestinal stromal tumor.